Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7191 p419-425
30 March 2002

This article
Reprint
Photocopy


News summary


Numark's risk-free trial

Numark is to allow its shareholders to order its top own-label products on a trial sale or return basis to overcome shareholder reluctance to try the products in their pharmacies.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal